Qingdao Haier (China) Today
| 688139 Stock | 33.28 0.36 1.09% |
Performance10 of 100
| Odds Of DistressLess than 9
|
Qingdao Haier is trading at 33.28 as of the 30th of November 2024, a 1.09 percent increase since the beginning of the trading day. The stock's open price was 32.92. Qingdao Haier has less than a 9 % chance of experiencing financial distress in the next few years and had a ok performance during the last 90 days. Equity ratings for Qingdao Haier Biomedical are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 1st of September 2024 and ending today, the 30th of November 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | Category Healthcare | Classification Health Care |
Qingdao Haier is entity of China. It is traded as Stock on SHG exchange. The company has 317.95 M outstanding shares. More on Qingdao Haier Biomedical
Moving together with Qingdao Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Qingdao Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Qingdao Haier's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Qingdao Haier or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Idea | Drugs (View all Themes) | ||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, Drugs, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | ||||
Qingdao Haier's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Qingdao Haier's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsQingdao Haier can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Qingdao Haier's financial leverage. It provides some insight into what part of Qingdao Haier's total assets is financed by creditors.
| |||||
Qingdao Haier Biomedical (688139) is traded on Shanghai Stock Exchange in China and employs 2,636 people. Qingdao Haier is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 10.58 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Qingdao Haier's market, we take the total number of its shares issued and multiply it by Qingdao Haier's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Qingdao Haier Biomedical operates under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 317.95 M outstanding shares.
Qingdao Haier generates positive cash flow from operations, but has no cash available
Check Qingdao Haier Probability Of Bankruptcy
Ownership AllocationQingdao Haier owns a total of 317.95 Million outstanding shares. Qingdao Haier has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Qingdao Ownership Details
Qingdao Haier Biomedical Risk Profiles
Although Qingdao Haier's alpha and beta are two of the key measurements used to evaluate Qingdao Haier's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.03 | |||
| Semi Deviation | 3.2 | |||
| Standard Deviation | 4.4 | |||
| Variance | 19.36 |
Qingdao Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Qingdao Haier without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Stock Screener Now
Stock ScreenerFind equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |
| All Next | Launch Module |
Qingdao Haier Corporate Management
Elected by the shareholders, the Qingdao Haier's board of directors comprises two types of representatives: Qingdao Haier inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Qingdao. The board's role is to monitor Qingdao Haier's management team and ensure that shareholders' interests are well served. Qingdao Haier's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Qingdao Haier's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jiangtao Zhang | Chief Engineer | Profile | |
| Guangsheng Wang | Deputy Manager | Profile | |
| Yanli Huang | Board Secretary | Profile | |
| Haitao Chen | Deputy Manager | Profile | |
| Ruijuan Mo | Chief Officer | Profile |
Other Information on Investing in Qingdao Stock
Qingdao Haier financial ratios help investors to determine whether Qingdao Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Qingdao with respect to the benefits of owning Qingdao Haier security.